Generic Tuberculosis Drug Shows Promise for Reversing Diabetes

Lock
This article is for subscribers only.

An 80-year-old drug used to protect people against tuberculosis may help reverse Type 1 diabetes, the most severe form of the disease, in patients who have had it for years, an early study in six patients found.

The medicine killed abnormal white blood cells that interfere with insulin production in the pancreas, according to the study presented at the American Diabetes Association meeting in San Diego. Patients getting two small doses four weeks apart showed signs of restored insulin production for about a week, Denise Faustman, director of the Massachusetts General Hospital Immunobiology Laboratory, said in a telephone interview.